The Garwood Medical Device solutions in development focus on improving
patient outcomes by treating the wound (EnerAid™), fighting implant infections, including antibiotic resistant bacteria (B.D.D. ™), and expedite healing of bone and enhance wound healing. These product innovations are possible based on Garwood’s innovative intellectual property portfolio.
The devices when fully developed in future generations will enable clinician control and bio-informatic reporting via telemetry. The clinician
will have control of the treatment parameters and receive operating and compliance reports, increasingly essential in today’s medical and insurance environment.